Concepedia

Joseph P. Lyssikatos

JP

Statistics

Publications

47

Citations

3.3K

H-Index

30

Active since

2002

Affiliations

Array BioPharma (United States)(Current)

Health and Functional Exposomics

WuXi AppTec (China)

Gene Therapy Laboratory

Charles River Laboratories (United Kingdom)

Joseph P. Lyssikatos is an author at Array BioPharma (United States) specializing in medicinal chemistry, drug discovery, and pharmacy.

Publications per year

2002–2021

47

Publications

47

Novel antibody–antibiotic conjugate eliminates intracellular S. aureus

Sophie M. Lehar, Thomas H. Pillow, Min Xu et al. · Nature · 2015 · 833 citations

Pharmacy, Infectious Diseases, Microbiology +10

Effect of selective LRRK2 kinase inhibition on nonhuman primate lung

Reina N. Fuji, Michael Flagella, Miriam Baca et al. · Science Translational Medicine · 2015 · 370 citations

Pharmacy, Pharmacology, Toxicology +13

Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

Anthony A. Estrada, Xingrong Liu, Charles Baker‐Glenn et al. · Journal of Medicinal Chemistry · 2012 · 164 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451

W. Gregory Roberts, Pamela Whalen, Erik Söderström et al. · Cancer Research · 2005 · 135 citations · Full text

Medicine, Oncology, Pharmacology +17

The Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis

Rishu Takimoto, Wenge Wang, David T. Dicker et al. · Cancer Biology & Therapy · 2002 · 128 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 47